Assistive technologies after stroke: self-management or fending for yourself? A focus group study by Sara Demain et al.
Demain et al. BMC Health Services Research 2013, 13:334
http://www.biomedcentral.com/1472-6963/13/334RESEARCH ARTICLE Open AccessAssistive technologies after stroke:
self-management or fending for yourself? A focus
group study
Sara Demain1, Jane Burridge1, Caroline Ellis-Hill2*, Ann-Marie Hughes1,3, Lucy Yardley4, Lisa Tedesco-Triccas1
and Ian Swain5,6Abstract
Background: Assistive Technologies, defined as “electrical or mechanical devices designed to help people recover
movement” have demonstrated clinical benefits in upper-limb stroke rehabilitation. Stroke services are becoming
community-based and more reliant on self-management approaches. Assistive technologies could become
important tools within self-management, however, in practice, few people currently use assistive technologies.
This study investigated patients’, family caregivers and health professionals’ experiences and perceptions of stroke
upper-limb rehabilitation and assistive technology use and identified the barriers and facilitators to their use in
supporting stroke self-management.
Methods: A three-day exhibition of assistive technologies was attended by 204 patients, family caregivers/friends
and health professionals. Four focus groups were conducted with people purposively sampled from exhibition
attendees. They included i) people with stroke who had used assistive technologies (n = 5), ii) people with stroke
who had not used assistive technologies (n = 6), iii) family caregivers (n = 5) and iv) health professionals (n = 6). The
audio-taped focus groups were facilitated by a moderator and observer. All participants were asked to discuss
experiences, strengths, weaknesses, barriers and facilitators to using assistive technologies. Following transcription,
data were analysed using thematic analysis.
Results: All respondents thought assistive technologies had the potential to support self-management but that this
opportunity was currently unrealised. All respondents considered assistive technologies could provide a home-
based solution to the need for high intensity upper-limb rehabilitation. All stakeholders also reported significant
barriers to assistive technology use, related to i) device design ii) access to assistive technology information and iii)
access to assistive technology provision. The lack of and need for a coordinated system for assistive technology
provision was apparent. A circular limitation of lack of evidence in clinical settings, lack of funded provision, lack of
health professional knowledge about assistive technologies and confidence in prescribing them leading to lack of
assistive technology service provision meant that often patients either received no assistive technologies or they
and/or their family caregivers liaised directly with manufacturers without any independent expert advice.
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Conclusions: Considerable systemic barriers to realising the potential of assistive technologies in upper-limb stroke
rehabilitation were reported. Attention needs to be paid to increasing evidence of assistive technology
effectiveness and develop clinical service provision. Device manufacturers, researchers, health professionals, service
funders and people with stroke and family caregivers need to work creatively and collaboratively to develop new
funding models, improve device design and increase knowledge and training in assistive technology use.
Keywords: Stroke, Upper limb, Assistive technology, Self-management, Patient, Family caregivers,
Health care professional, Rehabilitation, Qualitative researchBackground
Improved survival rates, increased prevalence of risk
factors, better long-term management and an aging
population are all predicted to contribute to the number
of people living with the effect of stroke worldwide [1,2].
Eighty per cent of stroke survivors have upper limb
impairments at stroke onset [3]. Estimates of recovery of
useful function among severely affected patients vary
widely depending on definition of ‘severe’ and ‘functional
recovery’. Examples are 18% [4] and 11.6% [5]. It is
generally agreed however, that loss of upper limb
function impacts on quality of life of the stroke survivor
and their family [6] as well as affecting ability to return to
work. Stroke outcomes impact on national economies
both through loss of employment and cost of health and
social care [7,8].
Average inpatient stay following stroke is decreasing and
is now 19 days in the UK [9] and 6.2 days in the US [10].
This means that increasingly rehabilitation is community-
based and with reduced opportunities one-to-one intensive
input for upper limb rehabilitation, which could affect
recovery [11] (Kwakkel 2004). Stroke is now considered a
long-term condition [12] and there is evidence in recent
trials of technologies used to support physical recovery up
to nine months post stroke, for example in the EXCITE
trial of Constraint Induced Movement Therapy [13].
Despite this, support even for ‘self-managed’ rehabilitation
beyond the first few months post-stroke is rare [14], and
research evidence and policy decisions have not translated
into practice.
Assistive Technologies, which we define as “electrical
or mechanical devices designed to help people recover
movement in their upper limb”, could be used to augment
conventional therapy and address the challenges facing
service providers. Assistive technologies may provide;
increased intensity of therapy without a corresponding
increase in clinical contact time, motivating relevant
activities, either functional or impairment based, and
can be used outside the hospital. They therefore have
great potential to improve the cost effectiveness of
upper limb stroke rehabilitation.
There is some evidence from clinical trials and system-
atic reviews to support the efficacy of a range of assistivetechnologies in upper limb stroke rehabilitation in
reducing impairments and in some cases improving func-
tion including: robot therapy [15], Electrical Stimulation
[16], Constraint Induced Movement Therapy [13] Virtual
Reality [17] and non-invasive brain stimulation [18]. Rapid
advances continue to be made in technology with com-
mensurate investment both from the commercial sector
and government funded research in The UK, Europe and
the US. Consequently assistive technologies are increas-
ingly used in clinical practice - often without established
research evidence. Indeed, a recent review by Burridge
and Hughes [19] identified that commercial drive is often
a more important factor in their use than research
evidence. It is likely that successful translation of assistive
technologies into clinical practice will depend not
only on robust, pragmatic research evidence but also
on understanding translational aspects such as the influ-
ence of the type of service provision, practical aspects of
device design and views of both service users and providers
on the relevance and usefulness of assistive technologies.
This research forms part of a larger programme of
research – the ATRAS project which covered four
areas a) the current treatment methods and outcome
measures used in England for upper limb rehabilitation
following stroke b) systematic reviews of what assistive
technologies exist to improve upper limb rehabilitation
following stroke c) the current project, all of which would
inform a clinical trial to assess the cost effectiveness of
assistive technology combinations. The aim of this research
was to identify current assistive technology knowledge and
service provision and the barriers and opportunities for
evidence based assistive technologies to be used in stroke
upper limb rehabilitation practice, as perceived by stroke
survivors, family caregivers and healthcare professionals.
Methods
A qualitative design was used comprising an interactive
exhibition and a series of four focus groups; two with
patients, one with carers and one with health professionals.
Ethical approval for the study was granted by the Isle of
Wight, Portsmouth and South East Hampshire Research
Ethics Committee (ref: 09/H0501/71) and consent was
given by participants before data collection.
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An interactive exhibition, with 12 different companies
displaying 27 different upper limb Assistive technologies
appropriate for stroke rehabilitation was held over 3 days
at the University of Southampton. A range of stakeholders,
including people with stroke, their friends, family members
who provided care or support to a person with stroke
(referred to as “family caregivers” throughout this
paper, commissioners, budget holders and clinicians,
and representatives from the local voluntary sector
were invited. The aims of the exhibition were to increase
stakeholder knowledge about assistive technologies, provide
an opportunity for people to try and compare devices and
to provide a useful means of recruiting relevant people to
the study. Two hundred and four people attended
(51% were people with stroke or family/friends and
49% were healthcare professionals). Delegates, many
of whom spent three or four hours at the exhibition,
were invited to ask questions and test each of the
technologies presented to consider whether they addressed
their needs. They were given a pamphlet illustrating the
assistive technologies with space to add their comments,
which they were invited to keep. Awareness was raised
about the research study, and people were invited to leave
contact and demographic details if they were willing to be
contacted about taking part in a focus group (n = 31 health
professionals; 32 patients and/or family caregivers).
Focus groups
Potential participants who registered an interest in taking
part in a focus group were purposively sampled in order
to gather views from a range of stake-holders a) people
with stroke of differing ages, genders, stroke severity, b)
differing professional backgrounds and c) those who iden-
tified themselves as family caregivers. The number of
focus groups was determined a priori, the main aim being
to capture the breadth of opinions of the various stake-
holders involved rather than to ensure data saturation for
each particular stakeholder group. Invitations to attend
focus groups on specified dates were sent to all those
who responded. Those willing and able to take part
on the dates specified (n = 21) were allocated to one
of the four focus groups: Focus Group 1: people who
had not used assistive technologies (n = 4 patients
and 1 family caregiver); Focus Group 2: people who
had used at least one assistive technology post-stroke
(n = 4 patients and 2 family caregivers; Focus Group 3:
family caregivers (n = 5; 1 of whom also attended focus
group 1); Focus Group 4: Healthcare Professionals (n = 6).
Inclusion criteria were a) stroke survivors, having a
previous stroke at any time b) family care givers, who
defined themselves as supporting a family member who
had had a stroke and c) health professionals – engaged in
stroke rehabilitation in the last 2 years. Although aphasiaand cognitive impairments were not exclusion criteria, all
participants were able to give informed consent. Focus
groups were appropriate for exploring the complex and
poorly understood issue of assistive technology use in
stroke rehabilitation because they encourage questions and
discussion, probe for depth, reflection on others’ opinions
and reconsideration of personal views [20,21].
Each focus group was held at the University of
Southampton and facilitated by a researcher (SD). An
observer (AMH) noted non-verbal aspects of the group as
is good practice when carrying out focus groups [22]. At
the beginning of each focus group the participants were
reminded that the researchers were interested in hearing
their views on the use of technologies for helping people
recover use of their arm and hand after stroke and
reminded of the technology which was on show at the
exhibition via individual information sheets and posters
around the room. Categories of assistive technologies
discussed were virtual reality (including commercially avail-
able gaming technologies such as the Nintendo Wii);
dynamic splints; biofeedback; robots; constraint induced
movement therapy and electrical stimulation. Four separate
topic guides were created. The overall content and struc-
ture of the topic guide was similar for each group but
modified slightly in address the needs of the participants.
The topic guide for all groups can be seen in Table 1.
Audio-recordings of each group were transcribed
verbatim; observed and noted non-verbal information
was incorporated into the transcripts. Pseudonyms
were allocated to maintain confidentiality. Data were
managed using NVivo 8 software (QSR International)
and analysed thematically [23].
Transcripts were read, re-read and coded inductively
by SD and AMH, cognisant of the research questions.
For instance the quote from the family care giver focus
group “we applied for funding and were turned down”
was coded as ‘funding application refused’. SD and
AMH discussed and grouped codes with related
meaning to generate emergent themes for each focus
group: for instance ‘funding application refused’ was
grouped with ‘purchasing private physiotherapy’ to form
the family focus group theme of ‘financial impact on
families’. Themes generated for each focus group were
then compared and contrasted across all focus groups to
highlight similarities and differences in the data and
generate the final overarching thematic structure presented
in the findings; for instance ‘financial impact for families’
(family caregivers focus group) was combined with
‘complex commissioning process’ (health professional
focus group) under the final overarching theme of ‘access
to assistive technologies. Codes and developing themes
were discussed with the wider research team throughout
this process to highlight alternative interpretations and
agree analytical decisions.
Table 1 Topic guide for the focus groups
Topics
All Groups Can I begin by asking what your overriding thoughts were about what you saw at the workshop?
What role do you think assistive devices should play in the rehabilitation of the hand and arm? Early after stroke
when people are still in hospital? In the first few weeks and months after people go home? What about longer
after stroke – say one or more years later?
Is there any other important information about the use of assistive technology in stroke rehabilitation that you
think we should know?
Group 1 I have been told that most of you here had not tried any of these technologies before attending the workshop,
is that correct? (If anyone has used assistive technology, we asked them to briefly explain what kind of technology
they used and what they thought about it)
For those of you who have not used assistive technologies, is this because you have never been offered them
in the past? If not offered we asked why do they think you have not been offered it? If offered we asked Why
did you decide not to use it?
Group 2 As a group of people who have used technologies to help with your arm rehabilitation what do you think are
the main advantages to using such devices? What about the main disadvantages?
Would some of you mind telling me about how you came to use an assistive technology?
If we could wave a magic wand and offer you any of the assistive technology devices you saw at the workshop
which would it be and why?
Were there any devices you would not be keen to use and why?
Group 3 What do you think are the main advantages of using assistive technology for the arm?
Do you think there are any disadvantages of using assistive technology for the arm?
Why do you think assistive devices are not used more in arm treatment?
What opportunities do you see for using assistive technologies in arm treatment in the future
If you could wave a magic wand and select one assistive technology device for your relative to use, which
would it be and why?
Which do you think would be least useful and why?
Group 4 What do you think are the main opportunities or advantages of using assistive technology in upper limb rehab?
Do you think there are any disadvantages to using assistive technology with the arm?
Which patients do you think assistive technologies are most useful for?
Are there any patients you would choose not to use assistive technologies with?
Why do you think assistive devices are not used more in upper limb? What opportunities do you see for using
assistive technology in upper limb rehab in the future rehabilitation?
If you could wave a magic wand and select one assistive technology which you think would be appropriate
for your patients and your service which would it be and why? Which do you think would be least useful and why?
Demain et al. BMC Health Services Research 2013, 13:334 Page 4 of 12
http://www.biomedcentral.com/1472-6963/13/334Results
Demographics of participants are provided in Table 2.
There were more women caregivers and more men with
stroke. Four of the family caregivers were partners of stroke
survivor participants. All stroke survivor participants had
experienced upper limb impairment post-stroke of whom
three had recovered functional use. Four patients had used
assistive technologies (robots, electrical stimulation
and dynamic splints) before the exhibition, none had
used virtual reality which was the most commonly
used assistive technology amongst the health professional
group. Conversely none of the health professional group
had experience with robot therapy.
The qualitative thematic analysis identified the poten-
tial of assistive technologies to support self-management
in stroke rehabilitation as a core concept in all the focus
groups. Three themes were also generated a) device design,b) access to information about assistive technologies,
and c) access to using assistive technologies. Each of
these themes impacted on stakeholders’ opportunity to
self-manage and experiences of and views on assistive tech-
nology use and provision. Pseudonyms (fictitious names)
are used throughout.
Assistive technologies as a tool for supporting
self-management in stroke rehabilitation
The potential of assistive technologies to facilitate
self-management was a core concept running through
each of the focus groups.
A focus on mobility and limited attention to arm
rehabilitation post-stroke has been noted previously
[24]. The patients and family caregivers in this study,
similarly reported a therapeutic emphasis on gait and
mobility whilst in hospital. They had assumed that
Table 2 Demographic details of the patient, family caregivers and health care professional cohorts
Patient (AT naïve and
experienced)
Family caregivers (AT naïve
and experienced)
Health care professionals
n = 8 n = 7 n = 6
Age (years) 46-79 44-82 Not applicable
Gender 1 female 6 female 5 female
7 male 1 male 1 male
Living situation 2 alone 1 alone Not applicable
6 with partner/spouse 6 partner/spouses
Time since stroke (years) 1-12 2-13 Not applicable
Employment status 1 working 1 working Qualified 6–24 years
Experience of using AT prior
to exhibition
4 none 4 none 1 none
4 prior experience 3 prior experience 5 prior experience
What ATs used before exhibition 1 Robot 1 Robot 3 ES
2 ES 1 ES 4 Dynamic Splints
1 Implanted ES 1 Implanted ES 4 Virtual reality
1 Dynamic Splints 1 Dynamic Splints /Computer games
Professional status Not asked Not asked 2 Physiotherapist (NHS) 1 Physiotherapist
(Private practice), 1 Occupational Therapist
(NHS), 1 Occupational Therapist (Social Services),
1 Clinical Registrar
AT Assistive technology, ES Electrical stimulation.
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greater priority, but for most people this was not the
case. They also reported a discontinuity between therapy in
hospital and at home, with long waits before home-based
therapy commenced and a reduction in the intensity when
it did. This was worrying for them. Many participants had a
lay understanding of the principles of neuroplasticity
and that intensity and repetition were necessary to
optimise functional recovery.
They concentrate very hard on getting you
walking again, which, quite right, it’s a priority,
but after all them getting you walking again,
there’s very little on, on the arm, in our experience.
[Marie; family caregiver; no prior assistive
technology use; focus group 1]
(It’s important to keep) brain cells, and nerve
endings, connected in some way, just keep it going.
I think the minute it all stops, it’s just wasted time
in the hospital… you know, you come out of hospital,
and they, they say they’ll give you an hours Physio a
week! [Sheila; family caregiver; prior assistive
technology use; focus group 3]
Assistive technologies were suggested as a solution to
this disconnect. People with stroke and their families
suggested that they could be taught how to apply and
use assistive technologies whilst in hospital, be providedwith an assistive technology to take home and then use
this to deliver intense, repetitive therapy both before and
after their home therapy commenced.
I think that it (assistive technology use) has
got to start before you are, before you are
discharged, to be able to carry it home, and
then do whatever it is you need to do afterwards.
[Susan; family caregiver; prior assistive technology
use; focus group 3]
The health professionals were more ambivalent about
using assistive technologies to facilitate the transition
home. The hospital-based therapists were concerned
about how they would find the time to prescribe and
teach people how to use assistive technologies, given the
focus on facilitating discharge.
the difficulty is there’s such a drive to get
patients out of hospital so early…you’re spending
a lot of your time getting them ready to be at
home, so you don’t have time.. I think that’s a real
challenge of how you start introducing assistive
technologies. [Maggie; OT; prior assistive
technology use; focus group 4]
But they recognised the potential for assistive tech-
nologies to provide intensive therapy and a means of
self-management.
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repetition, repetition, exercise, exercise, exercise
is hugely important… which is what we, as
staff can’t give them. [Sarah; physiotherapist
(private practice); prior assistive technology
use; focus group 4]
[assistive technology provision] is also preparing
people at the time when they go home … that they’re in
charge of it, you know, that they have a big role to play
in their rehabilitation. [Amy; occupational therapist;
prior assistive technology use; focus group 4]
All patient participants were keen to self-manage.
They were all actively engaged in looking for solu-
tions to promote arm recovery and were prepared to
spend time and, if necessary, money on potential
solutions, including assistive technologies as highlighted
by Keith:
(I want) something I could use every day….(not)
just go to a (physio) centre once a week or so
and by the time the six days has gone past not
using it you might be back where you were before.
[Simon; person with stroke; no prior assistive
technology use; focus group 1]
The opportunity for self-management was influenced
by a) device design b) access to information and access
to devices.
Device design for self-management
If assistive technologies are to support self–management
they need to be simple to apply, easy to use, motivating
and to provide feedback on performance.
Patients, family caregivers and health professionals all
recognised the motivational aspect of assistive technolo-
gies. They were seen as an improvement on routine
therapy; the fact that they were ‘hi-tech’ and designed
specifically for rehabilitation made them more credible
and enjoyable than traditional therapy exercises which
were often deemed to be boring and difficult to notice
improvement:
He would have spent hours on your robot because
it has flashing lights; it was connected to an
electricity source, and it looked hi-tech (laughter).
He would die before he will sit at home at the
table and do this (polish table) for 10 minutes at
a time, because, well, “it’s stupid, it’s pointless”.
And, and I think having a piece of equipment
makes, it also makes you feel you are actually
doing Physio. [Sheila; family caregivers; prior
assistive technology use; focus group 3]it’s a visual reminder, it’s a real … I got a girl to buy,
she had a, a Wii and she got the Guitar Hero, and my
goodness, (laughter) the improvement in her (yeah)
finger activity that helped her typing, but she didn’t
want to practice typing because she had to do that for
university study, but by using, you know, something
that is enjoyable and she could see, get some really
good visual feedback, Wow! The recovery she got was
absolutely fantastic. [Maggie; occupational therapist;
prior assistive technology use; focus group 4]
The preference for technological solutions seemed to
be particularly true of the younger, male patients in our
study; a view reiterated by the therapists, who also sug-
gested that patient acceptance of, and demand for, tech-
nologies would increase as the technical competency of
the population improved.
in the longer term 20 – 50 years down the line
everyone’s going to know what computers are (yeah)
and technology is, so , so you’ve got to look at that ,
the inter-activeness, and what’s on our computer
screen is going to become very important. And it has
to be goal orientated, like your guitar hero … So the
simplistic things [routine therapy], although they work
and they’re cheaper, they’re still not goal orientated
enough , I don’t think, for the clients to repeat it
enough to get the change and the plasticity that we’re
looking for. [Sarah; physiotherapist (private practice);
prior assistive technology use; focus group 4]
The time taken to prepare, set up and maintain assistive
technology devices was seen as a key issue for all stake-
holders. For therapists, the devices were viewed as a tool
for improving productivity and effectiveness by enabling
more patient practice hours per therapist. Concerns were
expressed about devices which needed complex adjustment
between patients (robots and dynamic splints), which
might be difficult to move to the patient (robots), which
were complex to programme (ES, robots), which were time
consuming to clean (most products) and difficult to store
(robots in particular). For patients and families, the devices
needed to be easy to get on and off a weak and/or
contracted hand/arm (problems identified with splints and
some robots) and to be intuitive in terms of correctly
positioning the device (problems identified with some
electrical stimulation devices and robots).
electrical stimulation is a lot of bother. I mean
Pete, it took Pete a long time before he was
confident of putting it on himself; he would always
call me, “Is it in the right place? Will you do it?”
[Sheila; family caregivers; prior assistive technology
use; focus group 3]
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(company representative) couldn’t even put it on my
hand … I can’t imagine if it would have to be done
every day. [Patricia; person with stroke; no prior
assistive technology use; focus group 1]
Make them (robots) much more user-friendly. I think
they are such big bits of kit. You can imagine, it’s like
taking an X-ray machine onto a ward…We’ve only got
in a day, 20 minutes, twice, to work on a limb. I prefer
to give them exercises and go, “just keep working, keep
working”. [Liz; physiotherapist; prior assistive
technology use; focus group 4]
Good device design is critical for self-management.
This research indicates that there is scope to improve
the design of currently available assistive technologies
It is clear that therapists, people with stroke and their
families can all provide useful feedback on and suggestions
for improvements in design.Access to information
Many of the patients had not known anything about
assistive technologies prior to attending the exhibition.
Several expressed amazement at what they had seen and
tried out and wished there were more similar opportunities
available. Other participants had used assistive technologies
for their leg but not been offered anything for their arm,
whilst others had used assistive technologies for their
arm whilst in hospital but had had to return the devices
on leaving hospital.
I was supposed to find that it (electrical stimulation)
would improve my hand, which it did. So I was
disappointed when it was taken away. And I said that
I was not happy with it being taken away, and it was
still taken away anyway. [Paul; person with stroke;
prior assistive technology use; focus group 2]
Several patient and family caregiver participants had
sought out information on assistive technologies. This
generally occurred after the people were discharged from
therapy but were still looking for a solution to their
persistent arm and hand disability. They gathered informa-
tion from a variety of sources; other people affected by
stroke who used assistive technologies, information in the
national press, the internet and from sales representatives.
Patient and family caregivers worried about the quality of
the information available from these sources and the
relevance of the information to their own situation.
They would have liked to be able to seek advice from
a therapist they knew and trusted.Participants in each group suggested that they had not
been given more information on assistive technologies by
therapists, because a) therapists were overworked, b) lacked
knowledge and training about what was available, and c)
were reluctant to give information about devices that they
could not provide within the state funded service.
I think their (health professionals’) time is very
constrained anyway, and that’s why they have this
problem with actually sort of using new equipment.
That’s my personal opinion. And it’s funding. It’s the
biggest issue of all. We (patients) might know what we
want; we know what we’d like (yep, yep, yep), it’s
actually getting it, you know. And all right, some
people can fund it themselves, but they still need to be
able to get to the right people to actually give them
that equipment…(its knowing) what you can and can’t
get…it’s a matter of education. [Martin; person with
stroke; prior assistive technology use; focus group 2]
it’s not showing us the things…you get such a very, very
negative… I mean we have had one or two fabulous
Physios, but if they aren’t enthusiastic about whatever
technologies you’ve researched and discovered work, and
if they’re not given the support and the time to use them,
then actually all the research on how good they are just
falls into a big black hole…. It’s the complete mind-set.
You know, the Physios were so disheartened. I think the
Physios tend very much to say “No it won’t work”
because they don’t want you thinking that there’s a
miracle cure that you can’t afford. So they’ll always try
and close down your options, because then you’re not
demanding things. [Sheila; family caregivers; prior
assistive technology use; focus group 3]
Interestingly one of the therapists confirmed these
opinions when she expressed her concerns over the time
pressures assistive technology prescription could generate
for her service:
I think there’s a number of patients that it would be
useful for but I think the cost versus the, not just the cost
financially, but the cost that you’d have to have people
coming in begging me for it. [Liz; physiotherapist; prior
assistive technology use; focus group 4]
The patient and family caregiver participants felt
strongly that health professionals should give them access
to information so that they could choose whether or not
to purchase equipment for themselves, as this discussion
demonstrates:
[Discussion in focus group 3 between Sheila and
Louis, two family caregivers]
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Louise: or answers the questions
Sheila: of the things that, you know, you could choose.
Or if you didn’t want to, you could choose not to
follow up. Because I think if the information’s given to
you, you would at least have a choice… Um, so more
advice and, and opportunity to see these things would
be tremendously helpful, because you could actually
make a balanced judgment.
As this was an issue over which patients and family
caregivers had expressed strong feelings we sought out
health professionals’ views about the level of information
provided. Many dilemmas were apparent including a)
the lack of strong research evidence for upper limb
assistive technologies, b) concerns over inequity in
assistive technology provision and c) tensions about
highlighting the existence of a device which may help
but which is not available from state-funded services. An
interesting contrast between the views of those working
in the state-funded system and the therapist working in
private practice was noted. Both the private and state-
funded physiotherapists agreed that the evidence base
underpinning the use of assistive technologies in stroke
arm rehabilitation was weak. Those working in the state
system said this made them reluctant to talk to patients
about assistive technologies in case it influenced them
or their families to purchase something that may not
work. In comparison, the private practice therapist
suggested that if a patient asked about a device they had
seen on the internet she would help them establish what
the evidence base was and, if they wanted, arrange a
meeting with the company representative. She indicated
that many patients and families were accessing this
information on the Internet anyway and that they needed
therapists’ support in making an informed decision.
However, both the state and privately funded therapists
indicated that, whilst they would respond to a patient’s
request for assistive technology information they would
not proactively inform about devices, for fear of creating
the impression of endorsing a product for which there
was insufficient evidence, as this discussion indicates:
[Discussion in focus group4 between Amy
(occupational therapist working in state
funded National Health Service) and Sarah
(physiotherapist working in private practice)]
Amy - There’s a bit of a moral dilemma there because
we’ve talked about there not being a lot of good evidence
for a lot of these things and how the NHS (state-funded
health service) can’t fund them. Personally I would have
a real issue with saying to someone, “There is this outthere; it may or may not work”, knowing that they’re in a
position in their life where they’re very emotionally
heightened, and may not be thinking the most rationally
they’ve ever done; they might also have cognitive impair-
ment; even their relatives might not be, you know, they’re
in, they’re in a state of shock or panic or whatever, and
to think that I might influence how someone goes and
spends their money, without good evidence.
Sarah: But, that’s exactly what you need to say to
the patient.
Amy: I’d have a bit of a moral dilemma with that.
Sarah: Because everyone at some point is active with
the internet, but again when they’re in the acute
setting, they’re not exactly, you know, on the
computer, but their relatives are.… I mean, my
patients come to me… I don’t know how many
times, they’ve Googled something new, and I’ll say,
“Fine, if you want to go and have a look at it, you
need to look at the evidence. I will not suggest this,
but it is out there.” So I think for the clients now,
they are so much more worldly wise, and we, we,
I think I struggle to keep up ….I think it is, it is
up to us to stand up and say, “Look, the evidence
isn’t there, we as therapists cannot say that you
need to go look at it, but if you’d like to I will
contact the company and set up a trial for you.”
Health professionals were not only concerned about
a lack of evidence for benefit they were also worried
about the potential risk of harm, especially if they
were to give advice about a device but could not
provide adequate follow-up to ensure its safe use in
the community.
If I can’t ensure that that follow-up is going to be
there, then I won’t provide it (assistive technology) to
them because it is potentially more detrimental for
them to just have it without a follow-up than for me
not to give it to them. [Lisa; physiotherapist; prior
assistive technology use; focus group 4]
HPCs’ concerns extended beyond the risks to the
patients and included risks of litigation to themselves
and their organisations:
In the age that we live in, you know with litigation
and what have you [laughs], it’s quite scary to
think that someone, you know, would misconstrue
something you might say as recommending that
thing, but then that doesn’t help them or does
them harm. [Amy; occupational therapist; prior
assistive technology use; focus group 4]
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were more willing to accept risks. In the absence of
health service provision, one couple had purchased their
own assistive technology device (electrical stimulation)
on-line. To do this, however, the patient’s wife (Mary)
had had to pretend that she was a health professional.
The sentiments expressed indicate that Mary thought
it safe for her and her husband to use the electrical
stimulation because they had already been shown
how to use it, could follow the instruction booklet
and her husband could feel whether he was getting
the right dose.
[Discussion between in focus group 3, between Mary
and Susan, two family caregivers:]
Mary: I just sort of bought a (electrical stimulation)
machine and carried on, because I couldn’t believe
that you could see it was doing some good, and then
you finish your re-hab time in hospital, and guess
what? It’s gone … So while we were in the rehab
hospital, I read the label on their machine, and I
phoned that company up, and she said, “Are you a
Physio?” And I said, “Sort of” (laughter). I got one
anyway.
Susan: Yes, and how did you get to know how to
use it?
Mary: because there’s an instruction booklet (OK),
and, he himself would know if it was too strong,
because of the toning, he could feel it. You know they
get like a tone after a stroke. They know how much
they can take and I would put it on very, very low.
Susan: How do you know where to put the sensors
though?
Mary: It tells you in the booklet.
Mary’s comments suggest that she considered her
and her husband to have sufficient expertise to use
the electrical stimulation. The questions from Susan
indicated a more cautious approach than Mary, but
interestingly, after the focus group, Susan asked Mary
for details of the electrical stimulation company with
a view to purchasing one for her husband.
A similar view of expertise was also expressed by one
of the patients. He suggested that patients could train
health professionals how to use certain assistive tech-
nologies because they (the patients) may be more famil-
iar with the devices than the therapists or nurses.
I think probably with the SaeboFlex, if you use it
for three of four times, if you get somebody new,
like a new Physio come in, you could tell her
(laughs) how to set it [Dan; person with stroke;
prior assistive technology use; focus group 2]The health professionals were also concerned about
the risk of giving false hope of recovery. In the absence
of clear evidence about the effectiveness of assistive
technologies, they worried that prescribing or giving
information about such devices would generate unrealistic
expectations which would be harmful for patients, and
difficult for therapists to manage.
[Discussion in focus group 4 between Liz
(physiotherapist working in National Health Service)
and Sarah (physiotherapist working in private practice]
Liz: But you have to be careful that we’re not giving
people some unrealistic expectation…hopefully people
will get better recovery from this, but my concern is, is
managing expectations which is quite hard.
Sarah: It’s also offering the patient false hope … you’re,
you’re building them up to a degree that it’s definitely
not going to solve. And patients do tend to hop from one
technology to the other, … it does become ridiculous,
because you get people coming out and showing you this
wonderful fandangled thing that’s not very useful.
The patients and family caregivers were aware of
health professionals’ reluctance to raise hopes and of the
arguments about lack of evidence. However, they were
less interested in generic findings, arguing that every
person with stroke is different and that evidence of benefit
should be sought on a case-by-case basis.
But it’s not just the fact of getting other people’s hopes
up when it’s an individual thing; because each one of
them will progress in a different way, and what helps
one won’t help another. So you can’t generalise a
stroke person I don’t think. [Mary; family caregivers;
prior assistive technology use; focus group 3]
One patient and his wife, who reported gaining benefits
from a trial of an upper-limb assistive technology, were
frustrated that the commissioners based their funding
decisions on generic evidence rather than on what they
believed had already been proven to ‘work’ for them. This
leads us to consider the provision of assistive technologies
and the implications for this on self-management.
Accessing equipment
A recurrent theme in all of the focus groups was the
lack of funding for upper limb assistive technologies.
This hampered the potential of assistive technologies
to facilitate self-management.
From the health professionals’ perspective the lack of
robust research evidence for upper limb assistive tech-
nology use was the biggest barrier to assistive technology
provision. They recognised that clinical guidelines did not
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limb rehabilitation, that much of the research was not
independent of the companies that endorsed the products
and that commissioners were faced with competing
demands on their budgets.
I took the upper limb electrical stimulation to the
priority committee and they discussed it at the same
time as lower limb (electrical stimulation). “Low
priority” [they said] “because the research isn’t solid to
back that up”. So that's going to be a real challenge to
go back to the commissioners and say, “Oh,
commission this for stroke services, you know, there
might be some benefit”. And they’re going to look and
go…actually that compared to this drug that we know,
if you give this drug three times a day we’re going to
put some heart condition, that’s going to make a, a
benefit compared to something that hasn’t got good
research. [Liz; physiotherapist; prior assistive
technology use; focus group 4]
On the other hand, the health professionals were also
keen to explore the effectiveness of assistive technologies
with individual patients. One therapist had organised a
training course to raise money for some dynamic splints.
She was hopeful that, if she could demonstrate individual
benefit, the orthotic department would be persuaded to
provide them for individual patients. Other therapists
indicated they had similar schemes to “trial” assistive
technologies with individuals, but that, even if these
trials indicated benefit, getting funding for individual
devices could not be assumed.
People with stroke and their family caregivers focussed
more on lack of funding rather than lack of evidence as
the reason why assistive technologies were not available.
Two people in our study had used an upper limb assistive
technology as part of their state-funded rehabilitation. In
both cases this was a temporary loan, with assistive
technology use ending due to hospital discharge rather
than, they believed, on the basis of a clinical rationale. The
patients and families typically believed that if a device was
demonstrated to ‘work for them’ that was sufficient
evidence that is should be provided for them, regardless of
transitions between hospitals or services.
Many of the patients and family caregivers also discussed
assistive technology cost as a barrier to them self-funding.
Some indicated that they would be prepared to self-fund
devices if they were able to test them first for personal
benefit. This, they indicated needed to be more than a sin-
gle trial with a company representative; they wanted to use
the device for a period of time to see if they could detect
benefits. As far as the patients and families were concerned
generic evidence was neither necessary nor sufficient; they
wanted to know it worked for them in their daily lives:if there was a way that you could have a bit of a trial
… then I think you, you might try and sort of scrimp
and save for, and try and get hold of one, but you
can’t do it on a whim. [Sheila; family caregivers;
prior assistive technology use; focus group]
Discussion
The findings as a whole indicate that these patients,
family caregivers and health professionals with an interest
in this area were all hopeful about the potential of assistive
technologies to facilitate self-management and improve
upper-limb recovery in stroke. The need to increase
intensity and repetition of upper limb exercise by facilitat-
ing independent practice was recognised by all. Assistive
technologies were seen as a potential solution to this.
Before focusing on the implications of these findings, it is
important to consider the framework of this research. This
research was conducted with people who had expressed an
interest in the use of upper-limb assistive technologies in
stroke-rehabilitation by attending an exhibition of assistive
technology devices. They should, therefore, not be consid-
ered representative of the whole population affected by and
working with stroke. By attending the exhibition and the
focus groups our participants are likely to have more
knowledge of and be more positive about the poten-
tial of assistive technologies than the population as a
whole. We did, however, seek to include the views of
a range of stakeholders that included people with
stroke and family care-givers with variations in gender and
age, who had experience of assistive technologies as well as
those who were naïve prior to the exhibition. Health
professionals were from the state and private sectors and
had a range of assistive technology experience. The strength
of this purposively selected group is that they were able to
give a depth of views from a range of perspectives. It would
be useful to carry out a wider survey of the issues to
explore the issues identified further and this is underway.
There are two main issues raised by our findings,
each of which will be discussed in turn: i) the urgent
need for evidence from clinical settings to support assistive
technology use in stroke upper-limb rehabilitation and ii)
other potential barriers to the use of assistive technologies
in the self-management of stroke.
From the patients’ and family caregivers’ perspective,
little therapy is currently being provided for their arms or
hands; assistive technologies offer the hope of improve-
ment, but they are unable to access unbiased professional
advice and risk buying products that may not meet their
needs. The extent of the effectiveness of different assistive
technologies has not been established in clinical settings.
Therapists are reluctant to provide advice on assistive
technologies, have difficulty assessing the impact of
assistive technologies on their practice, and cannot gain
funding for assistive technologies for their patients.
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disability is likely to increase as the population ages.
Gathering evidence for therapies which can be both
intense and used without therapist supervision, e.g.
assistive technologies would be a useful research priority
for governments and research funders. Assistive technology
use is often underpinned by sound theoretical and evidence
based principles at ‘experimental’ level. However transla-
tional work to everyday practice is needed which can take
into account the heterogeneous nature of the stroke
population, exploring the possible differences in benefits for
different groups (i.e. large/small infarcts, presence/absence
of somatosensory deficit, cognitive impairment etc.).
As well as the issue of research evidence, our findings
highlighted several issues associated with self-management
practice. The HPCs in this study felt that that many
people struggled to become active managers of their
own rehabilitation. However, the patients and family
caregivers described how they actively sought solutions to
their on-going upper-limb disability including searching for
information on the internet, contacting companies, and
purchasing their own assistive technologies. Kielmann et al.
[25], similarly identified people with respiratory illnesses
who saw themselves as active self-carers but who, like the
participants in our study, complained of obstacles within
the health system which acted as barriers to their self-
management and who felt abandoned by the health service.
Kennedy et al., [26] suggest that self-management cannot
focus only on educating patients how to self-care and
passing all responsibility for self-management to them.
They suggest that self-management requires a whole
systems approach which trains health professionals
how to work in partnership with patients, and which
encourages self-referral to services when patients need
advice. Such a partnership approach would be vital to more
routine use of assistive technologies in clinical practice.
Ensuring individuals can make informed choices and are
supported to use technology are considered key to pro-
moting self-management [24]. In contrast, the patients
and families in this study were frustrated that they were
not provided with information on assistive technologies
by experts who they could trust, realising that a lack of
expert advice increased the chance of them wasting their
money or purchasing a device which might do harm. Lack
of appropriate information is a recurring theme in audits
of stroke services [14,25]. Despite their frustrations,
the patients and families did not attribute the problem to
individual therapists, who they viewed as overwhelmed and
over worked; a barrier that professionals have recognised to
their engagement with self-management working [27].
Research suggests that many health professionals have
received little formal training to develop self-management
skills [28]. Stroke specific training in self-management
for staff working in stroke rehabilitation has recentlybecome available [29] but is still undergoing development
and evaluation.
A further concern, expressed by all stakeholders in this
study, was the usability of the devices; an issue which has
previously been reported as a barrier to self-management
by health professionals [30]. Our findings identified design
issues with the devices themselves which, if resolved, may
encourage the adoption of assistive technologies into
upper-limb rehabilitation. The use of an iterative design
process, which embeds stakeholder feedback throughout
the design cycle, is advocated [30]. Simply improving
the devices is not, however, likely to be enough. Other
psychosocial and organisational factors including commu-
nication channels, time, and the social system will also
impact on device uptake [31]. Moving from adoption
to the imbedding of technologies into routine practice
is also problematic. Normalisation Process Theory [32]
offers propositions to explain some of the integration
issues identified in this research. For instance, the problem
of ‘raising false hopes’ may hamper the integration of
assistive technologies into practice because of the inter-
actional challenge generated between professionals and
patients; whilst the systemic problems relate to issues
about the allocation and control of resources and how
assistive technology provision can be integrated into
existing patterns of activity. Both of these factors
pose challenges to the normalisation of assistive
technologies in rehabilitation practice that will need
to be addressed if they are to serve as useful tools
for self-management.
Conclusions
Assistive technologies are viewed as promising tools for
self-management in the rehabilitation of the upper limb by
patients, families and professionals but there are significant
barriers to their adoption and routine implementation in
practice. Most self-management interventions focus on
changing patient behaviour to encourage self-management,
but this was not found to be the most critical issue in this
study. The patients and families we spoke to demonstrated
many key self-management motivations and behaviours.
This research identified the devices, the evidence base,
patient-professional relationships and the health system as
the key barriers to the use of assistive technologies in
upper-limb rehabilitation. Assistive Technologies should
be co-designed by all stakeholders, and, given the
aging population and the drive for self-management
approaches, there is an urgent need to test their
effectiveness in pragmatic clinical trials, rather than
under ideal trial conditions, to expedite integration of
effective assistive technologies into routine practice. A
whole systems approach will be required which considers
training for professionals and system modification if the
promise of assistive technologies is to be realised.
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